A Disintegrin and Metalloproteinase with Thrombospondin Motifs (ADAMTS) is a family of enzymes that play vital roles in various biological processes such as extracellular matrix (ECM) remodeling, coagulation, and angiogenesis, among others. ADAMTS-15, like other members of this family, cleaves specific substrates within the ECM. The enzyme is regulated through multiple pathways, including transcriptional and post-translational modifications, as well as interactions with specific inhibitors and cofactors. Additionally, the availability of substrates within the ECM can influence its activity. The signaling networks that regulate ADAMTS-15 are complex and can involve various growth factors, cytokines, and hormones. Epigenetic mechanisms such as DNA methylation and histone acetylation can also impact its gene expression. Moreover, several signaling pathways, like TGF-β and Notch, can have downstream effects on ADAMTS-15 activity.
ADAMTS-15 activators can span a range of chemical classes and mechanisms of action. For instance, small molecules that inhibit opposing pathways-such as TGF-β inhibitors-can serve as indirect activators. Epigenetic modifiers like HDAC inhibitors that can alter the chromatin landscape around the ADAMTS-15 gene may also play a role in its activation. Some molecules may influence ADAMTS-15 through substrate availability, particularly those that impact the stability of the extracellular matrix. Other activators may function through complex signaling cascades involving reactive oxygen species (ROS) scavenging, or by interfering with pathways like Notch signaling, which have indirect effects on ADAMTS-15 expression and activity. It's crucial to understand that these activators work within a broader physiological context and may have different effects depending on other signaling events occurring within the cell or tissue.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
A derivative of vitamin A that can modulate gene expression and thereby potentially affect ADAMTS levels or activity. | ||||||
Heparin | 9005-49-6 | sc-507344 | 25 mg | $119.00 | 1 | |
This glycosaminoglycan can interact with some ADAMTS proteins and influence their activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol Esters can upregulate the expression of some ADAMTS proteins, although they are mainly used experimentally. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
A TGF-β inhibitor that can potentially upregulate certain ADAMTS enzymes by suppressing TGF-β signaling pathways that may downregulate ADAMTS expression. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
An HDAC inhibitor that may facilitate ADAMTS gene expression by altering the epigenetic landscape. | ||||||
GM 6001 | 142880-36-2 | sc-203979 sc-203979A | 1 mg 5 mg | $77.00 $270.00 | 55 | |
An MMP inhibitor that may help in maintaining the ECM substrates available for ADAMTS activity, thus potentially indirectly activating it. | ||||||
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $26.00 $119.00 $213.00 | 27 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $153.00 $938.00 | 5 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $57.00 $100.00 $250.00 | 129 | |
PDGF Small Molecule Inhibitors could potentially influence ADAMTS activity by interfering with growth factor-mediated ECM remodeling. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
An Nrf2 activator that might influence ADAMTS enzymes, particularly under conditions of oxidative stress. | ||||||